meibography

Why meibography can be a game-changer in treating dry eye
Why meibography can be a game-changer in treating dry eyeDry eye disease (DED) has been historically underserved. Leslie E. O’Dell, OD, FAAO, summarizes what equipment is available today to help you begin evaluating your dry eye patients’ glands.
Testing at point of care for improved patient satisfaction, re-treatment ratesAfter spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Why ODs should add meibography to their practices
Why ODs should add meibography to their practicesMeibomian gland imaging clearly has a role, yet most practitioners aren’t looking at meibomian glands at all.